Another kind of Guangxi production of new crown prevention and treatment drugs put into production to ensure the supply of new crown prevention and treatment drugs
Read Time:1 Minute, 9 Second
Recently, the reporter learned from the autonomous regional drug regulatory bureau, Guangxi revised pharmaceutical Co., Ltd. antipyretic acetaminophen tablets officially put into production, is another new Guangxi crown prevention and control drugs, a strong guarantee of the new crown prevention and control drugs supply.
December 25, 2022, after receiving the enterprise production application, the autonomous region drug regulatory bureau immediately formed a research group to carry out field research guidance, set up a working group to implement “one enterprise a policy” to help the enterprise precisely. The company’s difficulties and pain points for collective meetings and research, to speed up the production of specific advice and recommendations for pre-marketing preparations; open a green channel for administrative approval, the relevant applications with the review, fast review and approval; open emergency inspection and testing channel, with the inspection, testing and consulting services. In the joint efforts of all parties and rapid response, December 31, 2022, the autonomous region Drug Administration to Guangxi Xiuxiang Pharmaceutical Co., Ltd. issued “drug production license.
Ltd. submitted an application for change of production site and drug GMP compliance inspection in the early morning of January 14, and the review and approval personnel of each link completed the material review and approval procedures in the early morning of the same day. 17, Guangxi Xiuxiang Pharmaceutical Co., Ltd. is to carry out the antipyretic drug acetaminophen tablets batch production.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating